ARYA Sciences Acquisition Corp IV (ARYD)
NASDAQ: ARYD · IEX Real-Time Price · USD
11.40
+0.03 (0.26%)
May 17, 2024, 3:42 PM EDT - Market closed
Company Description
Arya Sciences Acquisition Corp IV does not have significant operations.
The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
It focuses on acquiring North American or European companies in the life sciences and medical technology sectors.
The company was incorporated in 2020 and is based in New York, New York.
ARYA Sciences Acquisition Corp IV
| Country | United States |
| Founded | 2020 |
| IPO Date | Feb 26, 2021 |
| Industry | Shell Companies |
| Sector | Financials |
| Employees | 3 |
| CEO | Adam Leo Stone |
Contact Details
Address: 51 Astor Place, 10th Floor New York, New York 10003 United States | |
| Phone | 212-284-2300 |
| Website | perceptivelife.com |
Stock Details
| Ticker Symbol | ARYD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0001838821 |
| CUSIP Number | G31659108 |
| ISIN Number | KYG316591083 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Adam Leo Stone | Chief Executive Officer and Director |
| Michael Seth Altman CFA | Chief Financial Officer and Director |
| Konstantin Poukalov | Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 16, 2024 | 425 | Filing |
| May 16, 2024 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| May 10, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| May 2, 2024 | 8-K | Current Report |
| May 2, 2024 | 8-K | Current Report |
| Apr 24, 2024 | 425 | Filing |
| Apr 24, 2024 | 8-K | Current Report |
| Apr 2, 2024 | 425 | Filing |
| Apr 2, 2024 | 8-K | Current Report |
| Mar 29, 2024 | 10-K | Annual Report |